These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10227432)

  • 21. Altered fractionation for head and neck cancer.
    Garden AS
    Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intensity Modulated Hyperfractionated Accelerated Radiotherapy to Treat Advanced Head and Neck Cancer - Predictive Factors of Overall Survival].
    Cvek J; Knybel L; Stránský J; Matoušek P; Res O; Zeleník K; Otáhal B; Molenda L; Skácelíková E; Stieberová N; Čermáková Z; Feltl D
    Klin Onkol; 2017; 30(4):282-288. PubMed ID: 28832174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered fractionation: limited by mucosal reactions?
    Kaanders JH; van der Kogel AJ; Ang KK
    Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC).
    Evensen JF; Sand Hansen H; Overgaard M; Johansen J; Andersen LJ; Overgaard J
    Acta Oncol; 2019 Oct; 58(10):1502-1505. PubMed ID: 31282236
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
    Staar S; Rudat V; Stuetzer H; Dietz A; Volling P; Schroeder M; Flentje M; Eckel HE; Mueller RP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1161-71. PubMed ID: 11483325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biweekly dose escalation in curative accelerated hyperfractionation for advanced head and neck cancer: a feasibility study.
    Kajanti M; Blomqvist C; Lehtonen H; Kouri M; Wiklund T; Holsti LR
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):837-40. PubMed ID: 9369131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head and neck cancer: altered fractionation schedules.
    Saunders MI
    Oncologist; 1999; 4(1):11-6. PubMed ID: 10337367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uninterrupted moderately accelerated radiotherapy in the treatment of unresectable/advanced head and neck cancer: one institution's experience and a comparative review.
    Dowlatshahi M; Iganej S; Ciabatone A; Peddada A; Miller M; Tome M; Rao A; Ryoo M; Becker G; McNicoll M; Morgan T; Ryoo J; Kagan R
    Am J Clin Oncol; 2000 Apr; 23(2):149-54. PubMed ID: 10776975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionation modification: a way to increase the biological dose?
    Ang KK
    Acta Otorhinolaryngol Belg; 1999; 53(3):227-30. PubMed ID: 10635398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG).
    Marcial VA; Pajak TF; Chang C; Tupchong L; Stetz J
    Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):41-7. PubMed ID: 3542916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of head and neck cancer with CHART and nimorazole: phase II study.
    Henk JM; Bishop K; Shepherd SF
    Radiother Oncol; 2003 Jan; 66(1):65-70. PubMed ID: 12559522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
    Bentzen SM; Saunders MI; Dische S
    Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.
    Glicksman AS; Wanebo HJ; Slotman G; Liu L; Landmann C; Clark J; Zhu TC; Lohri A; Probst R
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):721-9. PubMed ID: 9336155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of head and neck cancer: radiation therapy].
    Chatani M; Yoshino K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):271-6. PubMed ID: 8712818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Split-course accelerated hyperfractionation radiotherapy for advanced head and neck cancer: influence of split time and overall treatment time on local control.
    Akimoto T; Mitsuhashi N; Hayakawa K; Sakurai H; Murata O; Ishizeki K; Ishikawa H; Nasu S; Yamakawa M; Niibe H
    Jpn J Clin Oncol; 1997 Aug; 27(4):240-3. PubMed ID: 9379511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.